These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 4286683)

  • 41. Potency testing of inactivated tissue culture vaccine against Japanese encephalitis using antigen capture ELISA.
    Joshi AM; Walimbe AM; Banerjee K
    Acta Virol; 1997 Jun; 41(3):157-9. PubMed ID: 9385404
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Japanese B encephalitis virus vaccines from tissue culture. VII. Formalin inactivated Nakayama strain vaccine.
    Darwish MA; Hammon WM
    Proc Soc Exp Biol Med; 1966 Jul; 122(3):813-6. PubMed ID: 4288256
    [No Abstract]   [Full Text] [Related]  

  • 43. Reaction of Japanese encephalitis virus with mannan.
    Homma R
    Acta Virol; 1968 Sep; 12(5):385-96. PubMed ID: 4386631
    [No Abstract]   [Full Text] [Related]  

  • 44. Clinical studies of an attenuated virus cell culture venezuelan equine encephalomyelitis vaccine.
    Sampson GR; Elliston NG; Miyat JA; Grueter HP; Gillespie JR; Rathmacher RP
    Mod Vet Pract; 1973 Aug; 54(8):19, 21-2. PubMed ID: 4803525
    [No Abstract]   [Full Text] [Related]  

  • 45. Immunoglobulins produced in response to Japanese encephalitis virus infections of man.
    Ishii K; Matsunaga Y; Kono R
    J Immunol; 1968 Oct; 101(4):770-5. PubMed ID: 4176113
    [No Abstract]   [Full Text] [Related]  

  • 46. Okola (OKO) strain. YM 50-64.
    Am J Trop Med Hyg; 1970 Nov; 19(6):Suppl:1121-2. PubMed ID: 4395314
    [No Abstract]   [Full Text] [Related]  

  • 47. Mermet (MER) strain. AV-782.
    Am J Trop Med Hyg; 1970 Nov; 19(6):Suppl:1125-6. PubMed ID: 4992589
    [No Abstract]   [Full Text] [Related]  

  • 48. First isolation of a South American strain of Eastern Equine virus from a case of encephalitis in Trinidad.
    Corniou B; Ardoin P; Bartholomew C; Ince W; Massiah V
    Trop Geogr Med; 1972 Jun; 24(2):162-7. PubMed ID: 5037688
    [No Abstract]   [Full Text] [Related]  

  • 49. Protection of SA14-14-2 live attenuated Japanese encephalitis vaccine against the wild-type JE viruses.
    Jia L; Wang Z; Yu Y
    Chin Med J (Engl); 2003 Jun; 116(6):941-3. PubMed ID: 12877812
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ecological studies on Sindbis and West Nile viruses in South Africa. V. The response of birds to inoculation of virus.
    McIntosh BM; Dickinson DB; McGillivray GM
    S Afr J Med Sci; 1969 Oct; 34(3):77-82. PubMed ID: 5392770
    [No Abstract]   [Full Text] [Related]  

  • 51. Fractionation of Japanese encephalitis virus by column chromatography with calcium phosphate.
    Gaidamovich S; Myou DS
    Fed Proc Transl Suppl; 1966; 25(3):509-11. PubMed ID: 4287693
    [No Abstract]   [Full Text] [Related]  

  • 52. Japanese encephalitis protein vaccine candidates expressing neutralizing epitope and M.T hsp70 induce virus-specific memory B cells and long-lasting antibodies in swine.
    Fei-fei G; Jian W; Feng X; Li-ping S; Quan-yun S; Jin-ping Z; Pu-yan C; Pei-hong L
    Vaccine; 2008 Oct; 26(44):5590-4. PubMed ID: 18761388
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Various antibody holding status against viruses in Cercopithecus aethiops and Macaca irus. 3. The presence of antibodies to coxsackie, rubella, Japanese encephalitis, influenza and parainfluenza viruses.
    Takada M; Yamane Y; Nagashima T; Asahara T; Owada Y
    Kitasato Arch Exp Med; 1968 Dec; 41(3):135-51. PubMed ID: 4310558
    [No Abstract]   [Full Text] [Related]  

  • 54. Hemagglutination inhibition antibody titers against Japanese encephalitis virus from human and pig sera of Amami-Oshima Island.
    Doi R; Chinzei H; Oya A; Kobayashi M
    Jpn J Exp Med; 1967 Jun; 37(3):239-43. PubMed ID: 4296896
    [No Abstract]   [Full Text] [Related]  

  • 55. Laboratory diagnosis of Japanese encephalitis. Comparison of the fluorescent antibody technique with virus isolation and serologic tests.
    Kimoto T; Yamada T; Ueba N; Kunita N; Kawai A
    Biken J; 1968 Sep; 11(3):157-68. PubMed ID: 4305302
    [No Abstract]   [Full Text] [Related]  

  • 56. Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis.
    Guirakhoo F; Zhang ZX; Chambers TJ; Delagrave S; Arroyo J; Barrett AD; Monath TP
    Virology; 1999 May; 257(2):363-72. PubMed ID: 10329547
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of murine bone marrow-derived dendritic cells loaded with inactivated virus as a vaccine against Japanese encephalitis virus.
    Li Y; Xu M; Chen L; Zhu J; Ye J; Liu X; Sun Y; Chen H; Cao S
    Vaccine; 2009 Oct; 27(43):6004-10. PubMed ID: 19665607
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Immune globulin against Japanese encephalitis virus].
    Ogura R; Iwasaki T
    Saishin Igaku; 1967 Oct; 22(10):2147-55. PubMed ID: 4172574
    [No Abstract]   [Full Text] [Related]  

  • 59. [Study of immunoglobulin levels and antibody formation in allergic children].
    Saito H
    Arerugi; 1969 Apr; 18(4):263-76. PubMed ID: 4183796
    [No Abstract]   [Full Text] [Related]  

  • 60. Studies on Japanese B encephalitis virus vaccines from tissue culture. IX. Human response to a hamster-kidney tissue-culture inactivated vaccine.
    Darwish MA; Hammon WM; Sather GE
    Am J Trop Med Hyg; 1967 May; 16(3):364-70. PubMed ID: 4290334
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.